Perhaps more immediately regarding Friday’s milestone is a recent increase in cases per day. A week-long average of the country’s new daily cases moved above 53,000 – an increase of more than 55% in just one month, Johns Hopkins data showed.
Dr. Anthony Fauci, the country’s leading infectious disease specialist, warned that it was very high towards the end of the year.
“You can’t get into the cool autumn months and the cold winter months with the high baseline of infection in the community,” Fauci said at a virtual event at John Hopkins posted on Friday.
• At least two states, Illinois and North Carolina, are reporting their highest daily Covid-19 case to date on Friday, health officials said.
• Seven states saw a record for hospitals in Covid-19 on Thursday – Iowa, Kansas, Kentucky, Missouri, Montana, Oklahoma and Wisconsin, according to the Covid Tracking Project.
• Fourteen states set records for their seven-day average of new daily cases Thursday, according to Johns Hopkins.
And test positive is worse in some states – sitting above 20% Friday in Idaho, Iowa, South Dakota and Wisconsin. Experts along with Fauci say that increasing the rate of positivity predicts increases in cases, hospitals and deaths.
“It is critical that we really understand where this virus is spreading so that we can control cases and reverse positivity,” US Surgeon Jerome Adams said Friday at a news conference in Wisconsin.
‘Virus wins now’
More than 30 states have accumulated more new Covid-19 cases this past week compared to last week, according to data from Johns Hopkins.
The 14 states that have reached their maximum seven-day average of new daily cases are: Alaska, Colorado, Illinois, Indiana, Kansas, Missouri, Nebraska, New Mexico, North Dakota, Ohio, South Dakota , West Virginia, Wisconsin, and Wyoming.
The governor of New Mexico called his state’s coronavirus situation “the most serious emergency New Mexico has faced” Thursday.
The state’s positive review rate is 8.1%, Governor Michelle Lujan Grisham said. The average of new daily cases in a week – 457 to Thursday – was more than 400% higher than a point in early September.
That came just days after he issued new restrictions to help prevent the spread of the virus – including a limit on gatherings and a 10-hour closure for alcohol-based establishments.
“The virus has won today,” Lujan Grisham said. “We don’t have a water map.”
In parts of the state, intensive care units are “full,” according to New Mexico Health and Human Services Secretary David Scrase.
“This is a serious time for the state of New Mexico,” Scrase said, adding that the state curve for the seven-day average daily cases was “dwarfing past curve.”
Masks can save 70,000 lives
It should not be like this. Experts have repeatedly said that doubling down on simple safety measures including masks, social distance and hand washing can help slow the transmission of the virus.
Global studies have found that remdesivir does not help
The agency said it was “credible evidence” about the drug – and the findings were disappointing.
To date, remdesivir is the only drug that appears to have specific side effects for Covid-19 and is the only drug authorized for emergency use specifically for the virus from the U.S. Food and Drug Administration.
Prior to the WHO study, a large controlled study of remdesivir in the US was found to reduce the recovery time of nearly one-third of severe, hospitalized adults with Covid-19 , but less helpful for those with softer cases.
Gilead Science, the manufacturer of the drug, says that the findings do not mean that the drug is useless.
“Emerging data appear to be inconsistent with more robust evidence from numerous randomized, controlled studies published in peer-reviewed journals proving the clinical benefit of Veklury (remdesivir),” he said. Galaad in a statement. “We are concerned that the data from this open-label global test does not undergo the rigorous analysis necessary to allow for a good scientific discussion.”
CNN’s John Bonifield, Jason Hanna, Raja Razek, Ben Tinker and Amanda Watts contributed to this report.